5,629 results on '"Hyperparathyroidism, Secondary"'
Search Results
2. A Study of Etelcalcetide in Pediatric Subjects With Secondary Hyperparathyroidism and Chronic Kidney Disease on Hemodialysis
3. Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-2 (PATH-2)
4. Parathyroid Hormone (PTH) Attenuation Trial in Hemodialysis-1 (PATH-1)
5. The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKD (CaT50HD)
6. Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT (ACTIVE)
7. A Phase 3 Study of Etelcalcetide in Children With Secondary Hyperparathyroidism Receiving Hemodialysis
8. Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal Failure
9. Impact of Parathyroidectomy on Cardiovascular Calcification in Dialysis-dependent Patients
10. Phase 3 Safety and Efficacy Study of CTAP101 Extended-release Capsules in Children With Secondary Hyperparathyroidism
11. Investigating the Safety and Efficacy of SHR6508 Injection in the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients : A Multicenter, Long-term Clinical Trial
12. Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism
13. A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)
14. Changes in Cardiac Functions in Patients Treated With Parathyroidectomy for Secondary Hyperparathyroidism
15. A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
16. Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol (ECRIP)
17. Roles of Parathyroid Hormone and Fibroblast Growth Factor 23 in Advanced Chronic Kidney Disease
18. The Effect of Etelcalcetide on CKD-MBD (Parsabiv-MBD)
19. Diagnostic Accuracy of 3T MR for Secondary Hyperparathyroidism Comparison With 4DCT
20. A Trial of SHR6508 in Secondary Hyperparathyroidism
21. Precision Medicine Approaches to Renal Osteodystrophy (PMaROD)
22. A Study of SHR6508 in Secondary Hyperparathyroidism
23. FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease
24. Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under Dialysis
25. Safety and Efficacy of Hectorol in Pediatric Patients With Chronic Kidney Disease Stage 3 and 4 With Secondary Hyperparathyroidism Not Yet on Dialysis
26. Analysis of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory biomarkers in chronic kidney disease: impact of parathyroidectomy
27. A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation
28. Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency
29. Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa). (TeriCa)
30. E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events (EVOLVE)
31. A Study to Evaluate the Effect of ASP7991 in Secondary Hyperparathyroidism Patients Undergoing Hemodialysis
32. Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy (SZC)
33. Safety, Efficacy, PK and PD of CTAP101 (Calcifediol) ER Capsules for SHPT in HD Patients VDI
34. Frequency of Hyperparathyroidism in Postmenopausal Osteoporosis and Its Treatment
35. Study of KHK7580 in Subjects With Secondary Hyperparathyroidism in Asia
36. Suspected Deficient Activation of Vitamin D in Patients With Secondary Hyperparathyroidism (1hydroxylase)
37. A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism
38. Parathyroidectomy: still the best choice for the management of severe secondary hyperparathyroidism
39. Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients (PROCEED)
40. Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease (RLS)
41. Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism
42. A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant Patients
43. Pathogenesis of Compromised Bone Quality and Mechanics in Chronic Kidney Disease
44. Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)
45. Cinacalcet to Treat Hypercalcemia in Renal Transplant Recipients
46. Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease
47. Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment
48. Preemptive and Precise Intervention for CKD-SHPT
49. IOPTH Usefulness for Predicting Successful Surgery in Secondary Hyperparathyroidism
50. Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.